ChristopherKDaughertyMD

PubMed

• Clinical and molecular response of acute myeloid leukemia harboring non-canonicalN676K driver mutations to contemporary FLT3 inhibitors.
  Gregory W Roloff, Frank Wen, Aubrianna Ramsland, Andrew S Artz, Satyajit Kosuri, Wendy Stock, Olatoyosi Odenike, Richard A Larson, Hongtao Liu, Lucy A Godley, Michael ...> ;Haematologica. 2023 Aug 1
• Utilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer S...
  Fay J Hlubocky, Christopher K Daugherty, Jeffery Peppercorn, Karen Young, Kristen E Wroblewski, Seiko Diane Yamada, Nita K Lee> ;JCO Clinical Cancer Informatics. 2022 Aug 1
• 3 citations
  Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers.
  Fay J. Hlubocky, Tamara Goldman Sher, David Cella, Kristen Wroblewski, Jeffery Peppercorn, Christopher K. Daugherty> ;JCO Oncology Practice. 2021 Feb 10
• 43 citations
  Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, M...
  Fay J. Hlubocky, Banu E. Symington, Daniel C. McFarland, Colleen M. Gallagher, Konstantin H. Dragnev, John M. Burke, Richard T. Lee, Areej El-Jawahri, Beth Popp, Abby ...> ;JCO Oncology Practice. 2021 Feb 8
• 25 citations
  Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303
  Jennifer S. Temel, Jeff A. Sloan, Tyler Zemla, Joseph A. Greer, Vicki A. Jackson, Areej El-Jawahri, Mihir Kamdar, Arif H. Kamal, Craig D. Blinderman, Jacob J. Strand, ...> ;Journal of Palliative Medicine. 2020 Jun 9
• 1 citations
  A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed.
  Andrew Hantel, Fay J. Hlubocky, Mark Siegler, Christopher K. Daugherty> ;JCO Oncology Practice. 2020 May 29
• 1 citations
  Mistaking the Trees for the Forest
  Garth W. Strohbehn, Christopher K. Daugherty> ;The Oncologist. 2020 Apr 1
• 1 citations
  A Cross-Sectional Survey of Medical Trainee Experiences During Medication Shortages
  Andrew Hantel, Ashley M Egan, Trinh T Nguyen, Erin S. DeMartino, Fay J. Hlubocky, Samantha Bastow, Mark Siegler, Christopher K. Daugherty> ;Journal of Graduate Medical Education. 2020 Feb 1
• 3 citations
  Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials
  Sarah B. Garrett, Thea Matthews, Corey M. Abramson, Christopher J. Koenig, Fay J. Hlubocky, Christopher K. Daugherty, Pamela N. Munster, Daniel Dohan> ;JCO Oncology Practice. 2020 Jan 1
• 13 citations
  Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials
  Fay J. Hlubocky, Greg A. Sachs, Eric R. Larson, Halla Sayed Nimeiri, David Cella, Kristen Wroblewski, Mark J. Ratain, Jeffery Peppercorn, Christopher K. Daugherty> ;Journal of Clinical Oncology. 2018 Jul 9
• 19 citations
  Prevalence and Severity of Rationing During Drug Shortages: A National Survey of Health System Pharmacists.
  Andrew Hantel, Mark Siegler, Fay J. Hlubocky, Kevin J. Colgan, Christopher K. Daugherty> ;JAMA Internal Medicine. 2019 May 1
• Reply to J. Schildmann et al
  Fay J. Hlubocky, Christopher K. Daugherty> ;Journal of Clinical Oncology. 2019 Jan 10
• 12 citations
  Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials.
  Fay J. Hlubocky, Nancy E. Kass, Debra L. Roter, Susan Larson, Kristen E. Wroblewski, Jeremy Sugarman, Christopher K. Daugherty> ;Journal of Oncology Practice. 2018 May 22
• 65 citations
  Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
  Michael W. Drazer, Sabah Kadri, Madina Sukhanova, Sushant A. Patil, Allison H. West, Simone Feurstein, Dalein A. Calderon, Matthew F. Jones, Caroline M. Weipert, Chris...> ;Blood Advances. 2018 Jan 23
• 7 citations
  Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients.
  Laura B. Dunn, James Wiley, Sarah B. Garrett, Fay J. Hlubocky, Christopher K. Daugherty, Laura Trupin, Pamela N. Munster, Daniel Dohan> ;Psycho-Oncology. 2017 Oct 1
• 16 citations
  What advanced cancer patients with limited treatment options know about clinical research: a qualitative study.
  Sarah B. Garrett, Christopher J. Koenig, Laura Trupin, Fay J. Hlubocky, Christopher K. Daugherty, Anne Reinert, Pamela N. Munster, Daniel Dohan> ;Supportive Care in Cancer. 2017 May 9
• 6 citations
  An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population.
  Blase N. Polite, Toni Cipriano-Steffens, Fay J. Hlubocky, James J. Dignam, Mandira Ray, David J. Smith, Samir D. Undevia, Evie Sprague, Olufunmilayo I. Olopade, Christ...> ;Journal of Racial and Ethnic Health Disparities. 2017 Apr 1
• 467 citations
  Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
  Jonas A. De Souza, Bonnie J. Yap, Kristen Wroblewski, Victoria S. Blinder, Fabiana S. Araújo, Fay J. Hlubocky, Lauren Hersch Nicholas, Jeremy O'Connor, Bruce Brockstei...> ;Cancer. 2017 Feb 1
• 57 citations
  Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship.
  Lori Muffly, Fay J. Hlubocky, Niloufer Khan, Kristen Wroblewski, Katherine Breitenbach, Joseline X. Gomez, Jennifer L. McNeer, Wendy Stock, Christopher K. Daugherty> ;Cancer. 2016 Mar 15
• Is it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe
  Vijaya L. Rao, Christopher Daugherty> ;Clinical Liver Disease. 2015 Nov 1
• 14 citations
  User Beware: We Need More Science and Less Art When Measuring Financial Toxicity in Oncology
  Jonas A. De Souza, Bonnie J. Yap, Mark J. Ratain, Christopher K. Daugherty> ;Journal of Clinical Oncology. 2015 Mar 2
• 348 citations
  The development of a financial toxicity patient-reported outcome in cancer: The COST measure.
  Jonas A. De Souza, Bonnie J. Yap, Fay J. Hlubocky, Kristen Wroblewski, Mark J. Ratain, David Cella, Christopher K. Daugherty> ;Cancer. 2014 Oct 15
• 5 citations
  Human Subjects Protection: An Event Monitoring Committee for Research Studies of Girls From Breast Cancer Families
  Diana Harris, Linda Patrick-Miller, Lisa Schwartz, John D. Lantos, Christopher K. Daugherty, Mary B. Daly, Irene L. Andrulis, Saundra S. Buys, Wendy K. Chung, Caren J....> ;The Journal of Adolescent Health. 2014 Sep 1
• 127 citations
  General Internists’ Preferences and Knowledge About the Care of Adult Survivors of Childhood Cancer: A Cross-sectional Survey
  Eugene Suh, Christopher K. Daugherty, Kristen Wroblewski, Hannah Lee, Mackenzie L. Kigin, Kenneth A. Rasinski, Jennifer S. Ford, Emily S. Tonorezos, Paul C. Nathan, Ke...> ;Annals of Internal Medicine. 2014 Jan 7
• 140 citations
  Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer.
  Paul C. Nathan, Christopher K. Daugherty, Kristen Wroblewski, Mackenzie L. Kigin, Thomas V. Stewart, Fay J. Hlubocky, Eva Grunfeld, Marie Elisabeth Del Giudice, Leigh-...> ;Journal of Cancer Survivorship. 2013 Mar 8
• Join now to see all

Lectures

• Lower costs of care, improved discharge disposition, and improved survival of advanced cancer patients (ACP) receiving early inpatient palliative care (PC) compared to... 
  2019 ASCO Annual Meeting - 6/1/2019